Article
|
By Sungkeum Seo, Ph.D., and Jeremy Weisshar,
Samsung Biologics
A CDMO’s ability to scale seamlessly between bioreactor sizes is critical when adopting a client’s manufacturing process.
|
|
Article
|
By Ahmed Abouzeid and David Menahem,
Sartorius
Regardless of phase, media and mixing optimization can afford operators speed and efficiency for drug processing; likewise, failing to prioritize media preparation can compromise a process.
|
|
White Paper
|
By Kimberly B. Shepard, Amanda M. Pluntze, and David T. Vodak,
Lonza
Three combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.
|
|
White Paper
|
By Dr. Philippe Bunod, Julien Palisson, Jean-Charles Mougin, Come Sciard, Yannick Poirier, and Lukas Engel,
Pfeiffer Vacuum Inc.
Explore the results of a unique comparative study of CCIT and find a suitable deterministic test method to replace the blue dye test and follow the latest guidelines.
|
|
Case Study
|
By Shanna Stevens,
Catalent
A commercial packaging solution can be the first and enduring impression that a sponsor company makes on a patient, and its suitability can impact a biologic’s commercial success.
|
|
Poster
|
By Jonathan Bradshaw,
SMC Ltd.
Delivering high viscosity (HV) formulations with a truly human solution involves a balance between safety and practicality. Learn the importance of achieving this solution with HV autoinjector design.
|
|
Article
|
Thermo Fisher Scientific
Locking in the supply to support crucial production components in a landscape beset with unprecedented demand requires cross-functional, collaborative solutions from the industry’s biggest players.
|
|
Article
|
Cytiva
An assessment of the physical, chemical, and biological characteristics of representative complex media and feeds was made to compare pin mills and overall dry powdered medium manufacturing processes.
|
|
Article
|
Silverson Machines, Inc.
Creating a stable emulsion is a critical stage in the production of many pharmaceutical and cosmetics products. Learn about mixing equipment for successfully manufacturing emulsions.
|
|
Article
|
Adare Pharma Solutions
Taste masking is integral for a drug product’s final formulation. It can serve to increase patient acceptability and adherence to a therapy, in turn bolstering regulatory acceptance and commercial potential.
|
|
Article
|
DSM Biomedical
Patients facing osteoarthritis often experience excessive stiffness, limitations for mobility, difficulty sleeping, exhaustion, and bone-on-bone grating. Explore the challenges in current pain management options.
|
|
White Paper
|
Cambrex
Infrastructure and expertise cover the sweet spot for producing the small-to-midsize batches needed to meet industry demands for PDFs and orphan drugs, and also extend to large-scale manufacturing.
|
|
White Paper
|
Pfizer CentreOne
Development of novel small molecule APIs is increasingly turned over to outsourced partners who have become the primary drivers of the product’s overall development and go-to-market strategy.
|
|
Case Study
|
Wipotec
Serialization and aggregation solutions allow Swiss-based Acino Pharma to serve its international customers quickly and reliably.
|
|
Q&A
|
Pfizer CentreOne
Explore what it is like to lead an embedded CDMO within one of the largest pharmaceutical companies.
|
|
Webinar
|
West Pharmaceutical Services, Inc.
Using a comprehensive approach to component selection mitigates risks to fill/finish and lyo processing. Explore key considerations for selecting lyophilization stoppers suitable for intended use.
|
|
Webinar
|
Lonza
Internal specialized occupational toxicology and industrial hygiene knowledge can help solve the mystery of safe handling ADCs.
|
|